Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | MEDICAL EQUIPMENT AND ENGG COMPANYLikely | 9 | ₹738 |
| 2 | Schedule 2 | Prathmesh DistributorLikely | 1 | ₹2,244 |
| 3 | Schedule 3 | KUNDAN LIFESCIENCESLikely | 1 | ₹5,589 |
| 4 | Schedule 4 | MEDICAL EQUIPMENT AND ENGG COMPANYLikely | 1 | ₹15,228 |
| 5 | Schedule 5 | Not yet disclosed by govt.Likely | 39 | - |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
6 Mar 2025, 6:00 pmClosed
Nasal Drop Oxymetazoline Hcl 10 ml spray
Nasal Drop Xylometazoline Bott of 10 ml
Tab Bosentan 62 point 5mg
Tab Brivaracetam 50mg
Tab Clindamycin 100 mg plus Clotrimazole 200 mg suppository Tab
Tab Desvenlafexine 100 mg
Tab Desvenlafexine 50mg
Tab Eplerenone 25mg
Tab Feropenum Sodium 300 mg
RC Glycopyronium 25mcg plus Formoterol 12mcg plus budesonide 400mcg
Inj Darbepoietin 100 mcg
Clindamycin 1 percent w v Benzoyl peroxide 5 percent w w Gel 20gm
Pulv Mesalamine 1gm
Chlorphenamine Maleate 2 mg plus Phenylepherine 5 mg plus Dextromethorphan 10 mg plus Menthol 0 point 3 mg Syp 100 ml
Tab Carvedilol 25 mg
Tab Esmoprazole 20 mg
Tab Etophylline 77 mg plus Theophylline 23 mg
Tab Flecanide 50mg
Tab Flupirtine 100mg
Tab Ramipril 2 point 5mg plus Hydrochlorthiazide 12 point 5mg
Tab Sildenafil Citrate 25mg
Tab Sulphasalazie DR 1000mg
Tab Thiamine 100mg
Tab Tofisopam 50mg
Tab Verapamil 120 mg
Tab Clotrimazole Vaginal Pessary 100mg
Tab Etodolac 200mg
Tab Etoricoxib 120 mg
Tab Immipramine 25 mg
Tab Isosorbide 5 Mononitrate 20mg
Tab Isosorbide Dinitrate 10 mg
Tab Rasagiline 0 point 5mg
Tab Risperidone 4 mg
Tab Rivaroxaban 2 point 5 mg
Tab Rizatriptan 5 mg
Tab Secnidazole 1 gm
Tab Simvastatin 20 mg
Tab Tianaptine 12 point 5mg
Tab Cilostazole 50 mg
Tab Calcium Acetate 667mg
Tab Ivermectin 6mg
Tab Rifampicin 600mg plus Isoniazid 300mg Bid Number ( ) : GEM/2025/B/5948925 Dated : 13-02-2025 Bid Document 1/34
7521170
GEM/2025/B/5948925
Two Packet Bid
Nasal Drop Oxymetazoline Hcl 10 ml spray
20 days
Haryana; Ambala
Item wise evaluation
BOQ
6 documents required · 6 mandatory
3 yrs
₹3
30%
Exempted
6 Mar 2025
13 Feb 2025
6 Mar 2025
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|---|
| 1 | Nasal Drop Oxymetazoline Hcl 10 ml spray | Nasal Drop Oxymetazoline Hcl 10 ml spray | 60 | Bott | Ambala | 20 | |
| 2 | Nasal Drop Xylometazoline Bott of 10 ml | Nasal Drop Xylometazoline Bott of 10 ml | 330 | Bott | Ambala | 20 | |
| 3 | Tab Bosentan 62 point 5mg | Tab Bosentan 62 point 5mg | 460 | No | Ambala | 20 | - |
| 4 | Tab Brivaracetam 50mg | Tab Brivaracetam 50mg | 5,400 | No | Ambala | 20 | |
| 5 | Tab Clindamycin 100 mg plus Clotrimazole 200 mg suppository Tab | Tab Clindamycin 100 mg plus Clotrimazole 200 mg suppository Tab | 1,420 | No | Ambala | 20 | - |
| 6 | Tab Desvenlafexine 100 mg | Tab Desvenlafexine 100 mg | 500 | No | Ambala | 20 | |
| 7 | Tab Desvenlafexine 50mg | Tab Desvenlafexine 50mg | 1,400 | No | Ambala | 20 | - |
| 8 | Tab Eplerenone 25mg | Tab Eplerenone 25mg | 11,400 | No | Ambala | 20 | |
| 9 | Tab Feropenum Sodium 300 mg | Tab Feropenum Sodium 300 mg | 300 | No | Ambala | 20 | - |
| 10 | RC Glycopyronium 25mcg plus Formoterol 12mcg plus budesonide 400mcg | R C Glycopyronium 25mcg plus Formoterol 12mcg plus budesonide 400mcg | 600 | Bott | Ambala | 20 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7521170.pdf
GEM_BID
spec_bid_no_21_echs_2025-02-13-17-24-40_9293687f95a5894885229ec4589081da.pdf
BOQ
boq_item_sample_file_second_21_2025-02-13-17-24-40_fef06f3b49d21e7ee5a8d75fb98ddbed.csv
BOQ
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .